Announcements Trials
Browse Landscape

Status

Completed 208Recruiting 111Unknown 70Active not recruiting 51Terminated 46Withdrawn 19Not yet recruiting 13Enrolling by invitation 5No longer available 4Approved for marketing 2Suspended 1Available 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Expanded_access 4

Sponsor

Cancer Type

NET 4Endocrine 4

Conditions

Multiple Myeloma 20Melanoma 16Prostatic Neoplasms 15Neoplasms 15Recurrence 13Carcinoma, Non-Small-Cell Lung 13Leukemia, Myeloid, Acute 12Glioblastoma 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma 8Breast Neoplasms 7Sarcoma 6Neuroblastoma 6Lung Neoplasms 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6Leukemia 6Glioma 6Pancreatic Neoplasms 5Lymphoma, Non-Hodgkin 5Lambert-Eaton Myasthenic Syndrome 5Gastrointestinal Stromal Tumors 5Colorectal Neoplasms 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Neuroendocrine Tumors 4Liver Neoplasms 4Hodgkin Disease 4Carcinoma, Renal Cell 4Precancerous Conditions 3Pheochromocytoma 3

Interventions

Ga(III)-DOTATOC 2surufatinib 1Gallium-68 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
No longer available × Neuroendocrine Tumors × Clear all
NCT04814732 2024-04-12

Expanded Access Program of Surufatinib

Hutchmed

No longer available
EndocrineNET

Neuroendocrine Tumors

NCT02174679 2020-07-27

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Jonsson Comprehensive Cancer Center

No longer available
EndocrineNET

Carcinoma, Medullary, Neuroendocrine Tumors

NCT02375464 2016-11-08

Gallium-68 DOTATOC for Management of Neuroendocrine Tumors

Northwell Health

No longer available
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT02358018 2016-11-02

68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial

Memorial Sloan Kettering Cancer Center

No longer available
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡